Ignite Creation Date:
2025-12-25 @ 4:18 AM
Ignite Modification Date:
2025-12-26 @ 3:19 AM
Study NCT ID:
NCT06016920
Status:
RECRUITING
Last Update Posted:
2024-12-17
First Post:
2023-08-24
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Safety and Efficacy of VB10.16 and Pembrolizumab in Patients with Head-Neck Squamous Cell Carcinoma
Sponsor:
Nykode Therapeutics ASA
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-12-19
Start Date Type:
ACTUAL
Primary Completion Date:
2027-09
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-01
Completion Date Type:
ESTIMATED
First Submit Date:
2023-08-24
First Submit QC Date:
None
Study First Post Date:
2023-08-30
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-12-12
Last Update Post Date:
2024-12-17
Last Update Post Date Type:
ACTUAL